Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice

被引:52
作者
Mallet, VO
Mitchell, C
Guidotti, JE
Jaffray, P
Fabre, M
Spencer, D
Arnoult, D
Kahn, A
Gilgenkrantz, H
机构
[1] Cochin Inst, Dept Genet Dev & Mol Pathol, F-75014 Paris, France
[2] Cochin Inst, Biochem Lab, F-75014 Paris, France
[3] Hop Bicetre, Pathol Lab, F-94275 Le Kremlin Bicetre, France
[4] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[5] Hop Bichat Claude Bernard, INSERM, U9922, EMI, F-75877 Paris 18, France
关键词
D O I
10.1038/nbt762
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Studying the effects of the loss of a specific cell type is a powerful approach in biology. Here we present a method based on the controlled activation of the apoptotic machinery. We expressed a modified caspase-3-containing chemical inducer of dimerization (CID)-binding sites in the livers of transgenic mice. In the absence of CID, no liver injury was detectable, underlining the absence of leakage in our system. In contrast, injection of the CID produced activation of the chimeric caspase-3, which led to a dose-dependent pure hepatocyte ablation with subsequent regeneration. This method is effective in both growing and nongrowing cells, and is therefore applicable to a wide range of cells and tissues. Moreover, because apoptosis has been described in numerous pathological circumstances, this system is useful for generating mouse models of human disorders as well as for studying the recovery or regeneration of tissues after cell loss.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 39 条
[21]  
Krajewska M, 1997, CANCER RES, V57, P1605
[22]   Conditional lineage ablation to model human diseases [J].
Lee, P ;
Morley, G ;
Huang, Q ;
Fischer, A ;
Seiler, S ;
Horner, JW ;
Factor, S ;
Vaidya, D ;
Jalife, J ;
Fishman, GI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) :11371-11376
[23]   MEDICAL PROGRESS - ACUTE LIVER-FAILURE [J].
LEE, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1862-1872
[24]  
MATTHEWS T, 1988, REV INFECT DIS, V10, pS490
[25]   Hepatitis C virus replication in mice with chimeric human livers [J].
Mercer, DF ;
Schiller, DE ;
Elliott, JF ;
Douglas, DN ;
Hao, CH ;
Rinfret, A ;
Addison, WR ;
Fischer, KP ;
Churchill, TA ;
Lakey, JRT ;
Tyrrell, DLJ ;
Kneteman, NM .
NATURE MEDICINE, 2001, 7 (08) :927-933
[26]   Apoptosis and alcoholic liver disease [J].
Nanji, AA ;
Path, FRC .
SEMINARS IN LIVER DISEASE, 1998, 18 (02) :187-190
[27]   Apoptosis in heart failure:: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy [J].
Narula, J ;
Pandey, P ;
Arbustini, E ;
Haider, N ;
Narula, N ;
Kolodgie, FD ;
Dal Bello, B ;
Semigran, MJ ;
Bielsa-Masdeu, A ;
Dec, GW ;
Israels, S ;
Ballester, M ;
Virmani, R ;
Saxena, S ;
Kharbanda, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :8144-8149
[28]   Animal models of fulminant hepatic failure: A critical evaluation [J].
Newsome, PN ;
Plevris, JN ;
Nelson, LJ ;
Hayes, PC .
LIVER TRANSPLANTATION, 2000, 6 (01) :21-31
[29]   CELL LINEAGE ABLATION IN TRANSGENIC MICE BY CELL-SPECIFIC EXPRESSION OF A TOXIN GENE [J].
PALMITER, RD ;
BEHRINGER, RR ;
QUAIFE, CJ ;
MAXWELL, F ;
MAXWELL, IH ;
BRINSTER, RL .
CELL, 1987, 50 (03) :435-443
[30]   Dysregulation of apoptosis as a mechanism of liver disease: An overview [J].
Patel, T ;
Roberts, LR ;
Jones, BA ;
Gores, GJ .
SEMINARS IN LIVER DISEASE, 1998, 18 (02) :105-114